CHINA PH ARMACY Volume 33，Number 14，July 30，2022 Semimonthly Table of Contents Analysis of pediatric drug policies in China on the basis of policy tools
- VernacularTitle:基于政策工具的我国儿童用药政策分析
- Author:
Hongguo RONG
1
,
2
,
3
;
Qi LI
1
;
Yue DONG
1
;
Ruyu XIA
1
,
2
;
Yutong FEI
1
Author Information
1. School of Traditional Chinese Medicine，Beijing University of Chinese Medicine，Beijing 100029，China
2. Institute for Excellence in Evidence-based Chinese Medicine，Beijing University of Chinese Medicine，Beijing 100029，China
3. National Institute of Chinese Medicine Development and Strategy，Beijing University of Chinese Medicine，Beijing 100029，China
- Publication Type:Journal Article
- Keywords:
pediatric drug;
policy tool;
policy analysis;
content analysis method
- From:
China Pharmacy
2022;33(14):1665-1670
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To provide refere nce for the optimization and adjustment of the relevant policies in the field of pediatric drug in China. METHODS“Children”“pediatrics”and“drugs”were taken as the keywords to search the official websites of the State Council ，the National Health Commission ，the National Healthcare Security Administration ，the State Administration of Market Regulation and other relevant ministries and commissions ，and collect the relevant pediatric drug policies issued at the national level from January 1，2010 to December 31，2021. Content analysis method was used to summarize ，code and statistically analyze the policy tools used in the policy research documents. RESULTS A total of 39 policy documents and 327 policy tools were included in this study. According to statistics ，from 2011 to 2021，China issued national policy documents on pediatric drug use every year ，and in recent years ，the issuance of documents was relatively intensive. The main body of issuing pediatric drugs policy was the national health department and drug supervision and administration department （71.79％，28/39），and the number of documents issued by relevant ministries and commissions alone （76.92％，30/39）was significantly more than the number of documents jointly issued by multiple ministries and commissions （23.08％，9/39）. The environmental policy tools were the most widely used （64.83％，212/327），followed by s upply-oriented policy tools （30.28％，99/327），and demand-oriented policy tools were the least used （4.89％，16/327）. CONCLUSIONS The development of pediatric drug use in China is in its infancy. It is suggested that China should optimize supply-oriented policy tools，increase capital investment and the use of public health service tools ；adjust environmental policy tools ，accelerate the legislation of pediatric drugs ，and increase the proportion of incentive policy tool ；attach importance to demand-oriented policy tools ，strengthen international exchanges and the application of service outsourcing in the field of pediatric medication ；plan the use of various policy tools as a whole ，and coordinate the use proportion of three types of policy tool and their sub policy tools，so as to enhance the initiative of policy tools ，form policy synergy ，and jointly promote the development of pediatric drug use.
